Credentialing During M&A: NPI Changes, Reassignments, Revalidation

Credentialing during M&A is where deals quietly leak money. The clinical work continues, the sign changes, and everyone assumes the billing follows — until claims start denying because a Tax ID changed, a reassignment never pointed to the new entity, or an enrollment reset the effective date. Whether an acquisition or a TIN change breaks your revenue cycle comes down to a handful of decisions about NPIs, CMS change-of-ownership rules, reassignments, and re-contracting. Get them right and billing never blinks; get them wrong and you invite a blackout on work already performed.

What actually changes: TIN, NPI, and the billing entity

Start with identifiers, because they drive everything downstream. A Type 1 (individual) NPI belongs to the physician for life and travels with them through any deal. A Type 2 (organizational) NPI is attached to a legal entity and its Tax Identification Number (CMS NPI fact sheet). The pivotal question in any transaction is therefore simple: does the billing entity's TIN change? If the deal keeps the existing legal entity intact, the Type 2 NPI and its enrollments can often stay put. If the deal creates a new entity with a new TIN, you are effectively standing up a new billing organization — which usually means a new Type 2 NPI, new enrollments, and reassignments that must all be rebuilt to point at the new entity.

CHOW vs. new enrollment: the fork that decides your risk

Medicare treats acquisitions very differently depending on what is being acquired. For a certified Part A facility — a hospital, home health agency, ASC, or SNF — a formal change of ownership (CHOW) applies. Under the CHOW rule, the existing Medicare provider agreement is automatically assigned to the new owner, who steps into the seller's shoes and inherits the agreement subject to all its terms and conditions (42 CFR 489.18). Filed correctly and on time via the CMS-855A, a CHOW lets the facility keep billing continuously and avoids a blackout. But if the incoming owner does not file promptly and accept the assigned agreement, the MAC can hold or stop payments — so timing is everything (CMS Pub. 100-08 change-of-ownership guidance).

Physician groups are the trap, because Part B suppliers do not have a provider agreement to assign. There is no CHOW mechanism to carry a physician practice's Medicare enrollment across a new TIN. When a group is acquired into a new legal entity, Medicare treats it as a new enrollment — which resets the effective date and limits retrospective billing to just 30 days (42 CFR 424.520). That single distinction is the most common cause of an M&A billing blackout, and it is why deal teams must classify the target correctly before close, not after. Your MAC publishes practical CHOW sequencing tips worth following to the letter (MAC CHOW process tips).

Reassignments must be rebuilt

Every physician in a group has a reassignment on file that directs their Medicare payments to a specific billing entity. When the entity or TIN changes, every one of those reassignments has to be re-established to the new Type 2 NPI. This is not a formality — a physician can be fully credentialed and privileged, yet if their reassignment still points at the old entity, or points nowhere, their claims will not pay under the new organization. In a deal that moves dozens of providers at once, rebuilding reassignments is the highest-volume, most error-prone task on the enrollment side, and the one most likely to be discovered only when the first post-close remittance comes back short. Watch NPPES as well — organizational NPI records carry addresses and authorized officials that must be updated to reflect the new ownership, and stale NPPES data can spawn its own claim edits.

Re-contracting with commercial payers

Government programs are only half the picture. Commercial payer contracts generally do not travel automatically with an acquisition. Each payer has to be notified, the new TIN loaded to its systems, fee schedules re-linked, and in many cases providers re-credentialed under the acquiring organization before claims will adjudicate correctly. Payers move on their own timelines, so a group that waits until after close to start re-contracting can face weeks or months of denials from its largest commercial books. The defense is a payer-by-payer matrix built during due diligence: every contract, its assignment or notification requirement, and its expected turnaround, sequenced so the highest-volume payers are handled first. Do not overlook delegated credentialing and CAQH: the acquiring organization's CAQH roster must reflect the moved providers, and any delegated agreements have to be reassigned or renegotiated before they can be relied on.

Mass revalidation and effective-date traps

Because any "new" enrollment created by the deal is subject to the standard effective-date and 30-day retrospective-billing limits (42 CFR 424.521), a late-filed transaction converts directly into unbillable days. The larger the roster, the larger the exposure, because a single mis-sequenced tie-in can strand hundreds of claims. Coordinate the enrollment wave deliberately: file early, sequence the Medicare tie-in against the corporate close, and run Medicaid and every affected MCO in parallel, since state programs have their own change-of-ownership and re-enrollment rules that rarely align with Medicare's. In fact, some state Medicaid programs run their own change-of-ownership review that can take longer than Medicare's, so the state timeline — not the federal one — often becomes the binding constraint on go-live. The financial stakes make this worth over-resourcing — the same lost-revenue math that governs a single slow hire scales brutally across an entire acquired group (MGMA).

Due diligence: what to demand before close

The enrollment side of M&A diligence is its own checklist, and the time to run it is before the deal closes, not after. Ask the seller for a complete provider roster with every Type 1 and Type 2 NPI, active PTANs, and current Medicare and Medicaid enrollment status; every commercial payer contract and its assignment language; a schedule of upcoming revalidation due dates; and any open corrective action plans, sanctions, or exclusions. For acquired facilities, confirm whether an existing plan of correction will carry to the new owner under the assigned provider agreement. Run OIG and SAM exclusion checks on every acquired provider and entity, because inherited liabilities travel with the deal. Gaps found in diligence are cheap to fix; the same gaps found after close, while claims are denying, are expensive and public.

Avoiding the billing blackout: an M&A runbook

The groups that transition cleanly start early and inventory everything:

• Classify the target — Part A CHOW versus Part B new enrollment — before close, because it dictates the entire plan.
• Inventory identifiers — every Type 1 and Type 2 NPI, TIN, PTAN, reassignment, and payer contract in scope.
• Begin 90 to 120 days ahead so effective dates land on or before the close, not after it.
• Keep the seller's enrollment in good standing until the tie-in is confirmed, so there is no coverage gap between old and new.
• Sequence the wave — Medicare tie-in, reassignments, Medicaid, and MCO re-contracting — against the corporate timeline.

M&A magnifies every credentialing weakness a group already has, so the transaction is a forcing function to get the fundamentals right. Reinforce it with clean Medicare enrollment via PECOS, a firm grip on the credentialing versus payer-enrollment split, vigilance against a recredentialing lapse, and — for any acquired facilities — a solid facility credentialing playbook.